ACTIGALL
Pronunciation: ER-soe-dye-ol


What it isHydrophilic bile acid that displaces toxic bile acids; primary biliary cholangitis and cholesterol gallstones.
Why this oneThe only treatment that improves transplant-free survival in primary biliary cholangitis.
What limits itIt dissolves only small, non-calcified cholesterol stones, and slowly. Diarrhea; stones recur when it is stopped.
Principal riskDiarrhea
Legacy pregnancy categoryUnknown / historical label unavailable
Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Radiolucent noncalcified gallbladder stones <20 mm (dissolution; surgery high-risk or refused) | Adults | 8-10 mg/kg/day in 2 or 3 divided doses | 8-10 mg/kg/day | Undefined (safety beyond 24 months not established) |
| Gallstone prevention in obese patients with rapid weight loss | Adults | 300 mg BID | 600 mg/day (300 mg BID) | Undefined |
Renal Undefined
Hepatic Undefined
Dissolution: gallbladder ultrasound every 6 months in year 1; confirm dissolution with repeat ultrasound within 1 to 3 months; success unlikely if no partial dissolution by 12 months. AST/ALT at initiation
Available strengths
Pregnancy No fetal harm in animal studies at 20- to 100-fold human dose; no adequate human studies; not recommended during pregnancy
Lactation Unknown if excreted in human milk; use caution in nursing mothers
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 150 mg | cap | per unit | not offered | |
| 200 mg | cap | per unit | not offered | |
| 300 mg | cap | per unit | $0.43/ea | offered |
| 400 mg | cap | per unit | not offered |
Generic entry2000
Open Ursodiol in the interactive console ↗